Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: E9AR59
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.796 |
CLV_PCSK_PC1ET2_1 | 72 | 74 | PF00082 | 0.710 |
CLV_PCSK_SKI1_1 | 28 | 32 | PF00082 | 0.749 |
DEG_MDM2_SWIB_1 | 7 | 14 | PF02201 | 0.759 |
DOC_USP7_MATH_1 | 82 | 86 | PF00917 | 0.735 |
DOC_USP7_MATH_1 | 93 | 97 | PF00917 | 0.599 |
DOC_USP7_UBL2_3 | 20 | 24 | PF12436 | 0.703 |
LIG_14-3-3_CanoR_1 | 28 | 35 | PF00244 | 0.700 |
LIG_14-3-3_CanoR_1 | 73 | 78 | PF00244 | 0.577 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.735 |
LIG_BRCT_BRCA1_1 | 3 | 7 | PF00533 | 0.647 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.620 |
LIG_FHA_2 | 14 | 20 | PF00498 | 0.761 |
LIG_LIR_Apic_2 | 33 | 38 | PF02991 | 0.776 |
LIG_Pex14_2 | 3 | 7 | PF04695 | 0.725 |
LIG_PTB_Apo_2 | 94 | 101 | PF02174 | 0.606 |
LIG_PTB_Phospho_1 | 94 | 100 | PF10480 | 0.606 |
LIG_SH2_CRK | 143 | 147 | PF00017 | 0.753 |
LIG_SH2_CRK | 35 | 39 | PF00017 | 0.764 |
LIG_SH2_GRB2like | 35 | 38 | PF00017 | 0.766 |
LIG_SH2_NCK_1 | 143 | 147 | PF00017 | 0.617 |
LIG_SH2_NCK_1 | 35 | 39 | PF00017 | 0.764 |
LIG_SH2_SRC | 35 | 38 | PF00017 | 0.766 |
LIG_SH2_STAP1 | 143 | 147 | PF00017 | 0.539 |
LIG_SH2_STAP1 | 88 | 92 | PF00017 | 0.554 |
LIG_SH2_STAT3 | 130 | 133 | PF00017 | 0.836 |
LIG_SH2_STAT3 | 88 | 91 | PF00017 | 0.555 |
LIG_SH2_STAT5 | 130 | 133 | PF00017 | 0.748 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.574 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.731 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.786 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.637 |
MOD_CK2_1 | 13 | 19 | PF00069 | 0.756 |
MOD_CK2_1 | 51 | 57 | PF00069 | 0.503 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.642 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.775 |
MOD_GlcNHglycan | 84 | 87 | PF01048 | 0.762 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.785 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.705 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.727 |
MOD_PK_1 | 44 | 50 | PF00069 | 0.697 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.795 |
TRG_DiLeu_BaEn_1 | 25 | 30 | PF01217 | 0.775 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.593 |
TRG_ENDOCYTIC_2 | 143 | 146 | PF00928 | 0.754 |
TRG_NLS_MonoCore_2 | 71 | 76 | PF00514 | 0.544 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IAS9 | Leishmania donovani | 87% | 100% |
A4H950 | Leishmania braziliensis | 53% | 89% |
A4HXG4 | Leishmania infantum | 88% | 100% |
Q4QEA4 | Leishmania major | 82% | 100% |